National Science Foundation

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Norwich University is a nonprofit educational institution located in Northfield, Vermont, founded in 1819. It offers a diverse range of academic programs, including undergraduate degrees in liberal arts, sciences, and professional fields such as Architecture, Computer Science, Engineering, Pre-Law, and Pre-Medicine. The university is notable for its ROTC program, which trains cadets while also accommodating non-cadets who seek high-quality education. Graduate degrees are predominantly delivered online, with options available in Diplomacy, Education, Military History, Civil Engineering, Public Administration, and Nursing. Norwich employs an experiential learning model that integrates practical and theoretical approaches to education, enhancing knowledge retention. The university provides various financial aid opportunities, including loans, grants, and scholarships, particularly benefitting current and former military personnel. Admission requirements include submission of an application, a personal statement, transcripts, test scores, and letters of recommendation, which are strongly encouraged.

Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By utilizing advancements in bioengineering and nanotechnology, the company specializes in the sensitive detection of viral, bacterial, and fungal pathogens without relying on nucleic acid amplification techniques. This innovative approach allows for the delivery of granular and clinically actionable information, thereby improving traditional testing methodologies and enabling healthcare providers to make informed decisions more swiftly.

Case Western Reserve University (CWRU) is a private research university located in Cleveland's University Circle. Established in 1843, it comprises various schools including Medicine, Law, Engineering, Arts and Sciences, Nursing, Social Sciences, Dental Medicine, Management, and Mandel School of Applied Social Sciences. CWRU is renowned for its biomedical discoveries, medical education, and top-ranked programs such as international law, health law, and intellectual property law. It offers practical experiences like real-client work and full-time practice experiences to students across various disciplines. The university is accredited by several professional associations and holds membership in the Association of American Universities.

Moshion is a technology company specializing in healthcare workflow optimization, specifically targeting the nursing shortage. It employs 3D image sensors, preserving patient privacy, to gather movement data, which is then analyzed using machine learning models. Moshion's primary focus is to prevent pressure injuries in bedridden patients by monitoring and optimizing patient turning protocols. The platform tracks adherence to these protocols, provides personalized turn schedules, sends reminders to nurses, and automates documentation. This data-driven approach aims to enhance patient care, improve nursing efficiency, and reduce the risk of life-threatening events.

Tiny Cargo specializes in a unique drug delivery system utilizing non-immunogenic bovine milk-derived exosomes. This innovative approach allows for the effective oral or intravenous administration of potent therapeutics. The company focuses on delivering treatments for various serious health conditions, including ischemic heart disease, gastrointestinal radiation disease, and glioblastoma multiforme, among others. By leveraging its technology, Tiny Cargo aims to enhance the delivery of peptide drugs, making it applicable to a wide range of current peptide therapeutics and improving patient outcomes in the treatment of neurological and other pathologies.

JelikaLite specializes in developing medical equipment for children with autism spectrum disorders, focusing on non-invasive methods to enhance brain health. Their primary product is a wearable device that integrates infrared light, EEG sensors, and an artificial intelligence personalization platform. This therapeutic device aims to reduce the symptoms of autism by promoting improvements in speech, decreasing anxiety, and enhancing responsiveness in pediatric patients. By utilizing innovative therapies, JelikaLite seeks to provide lasting benefits for children dealing with autism, emphasizing a commitment to advancing pediatric neurological health.

Oxalo Therapeutics is focused on developing innovative drug therapies aimed at treating rare kidney diseases and preventing recurring kidney stones. The company specifically targets primary hyperoxaluria and other oxalate-related pathologies through a novel approach that utilizes a gut bacterium to facilitate the safe removal of oxalate from the body. By mimicking natural mechanisms, Oxalo Therapeutics seeks to provide effective treatment options for patients suffering from conditions associated with high levels of oxalate, thereby improving their quality of life and reducing the incidence of kidney stone recurrence. The company's expertise in the microbiome and translational research underpins its commitment to advancing early-stage technology in the field of kidney health.

HairDays is an AI-powered health data company that has developed a unique hair intelligence platform focused on simplifying hair classification and care. The platform provides tailored recommendations for maintaining healthy hair, allowing consumers to discover and purchase hair care products suited to their individual needs. By curating relevant content, HairDays enables users to monitor their hair conditions and track their growth progress effectively. This innovative approach eliminates the guesswork often associated with hair care, empowering individuals to make informed decisions about their hair health.

Levisonics is a manufacturer of advanced blood coagulation instruments that specialize in non-contact analysis for blood coagulation and fluid quality control testing. Their products facilitate the assessment of bleeding and thrombosis risks through innovative fluid rheological measurement techniques. In addition to medical applications, Levisonics' technology can be employed in real-time monitoring of the quality of food, liquid, and gel products during production or processing, ensuring safety and compliance in various industries.

Intelligent Medicine specializes in software and simulation services focused on enhancing safety in medical environments through innovative technologies. The company has developed a simulation platform that enables architects and facility stakeholders to evaluate and optimize building designs and operational protocols. By testing various designs and protocols, the platform helps to identify areas for improvement, thereby reducing the likelihood of infectious disease transmission and alleviating user congestion. This capability allows for a rapid feedback loop, supporting the planning and implementation of effective safety policies and design strategies to improve overall outcomes in healthcare settings.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Nanopath Inc. is a molecular diagnostics company focused on enhancing women's health through rapid and precise testing. By utilizing advancements in bioengineering and nanotechnology, the company specializes in the sensitive detection of viral, bacterial, and fungal pathogens without relying on nucleic acid amplification techniques. This innovative approach allows for the delivery of granular and clinically actionable information, thereby improving traditional testing methodologies and enabling healthcare providers to make informed decisions more swiftly.

Averto Medical is a manufacturer of medical devices focused on addressing gastrointestinal diseases. The company specializes in developing innovative solutions designed to facilitate minimally invasive colorectal tumor removal, which aims to reduce the need for multiple surgical procedures and associated complications. By providing effective medical care options for patients suffering from gastrointestinal disorders, Averto Medical seeks to improve patient outcomes and streamline treatment processes in this critical area of healthcare.

CorInnova Incorporated, founded in 2004 and based in Houston, Texas, specializes in device-based therapies aimed at treating congestive heart failure. The company is known for its innovative non-blood-contacting soft robotic cardiac assist device, which has the potential to significantly increase the number of heart failure patients eligible for life-saving device therapies. By focusing on advanced technological solutions, CorInnova seeks to improve outcomes for individuals suffering from this serious condition.

Pragma Health provides digital healthcare services. They permit users to perform different tests for cardiovascular, hematology, infectious diseases, and others in the privacy of their home and provide accurate, immediate results, enabling them to get a convenient, cost-effective, and accurate healthcare testing process.

Compact Medical Solutions LLC is a company that specializes in developing innovative medical devices, specifically a bag-valve-mask (BVM) known as the Butterfly BVM. Founded in 2016 and headquartered in Indianapolis, Indiana, the company focuses on creating an ultra-compact breathing device that aids medical personnel in managing emergency breathing situations. The Butterfly BVM enhances resuscitation efforts by preventing hyperventilation, thereby allowing for safer ventilation of patients experiencing respiratory distress.

Innsightful offers a comprehensive digital health solution aimed at managing and alleviating mental health challenges, particularly for students. The company develops wearable devices that monitor and detect symptoms of anxiety and stress, utilizing artificial intelligence and machine learning to provide automated, early detection of heightened stress levels. These devices integrate biometrics to give users personalized insights, fostering a deeper understanding of their mental health. Additionally, Innsightful facilitates access to therapists for tailored recommendations and progress assessments, transforming how individuals approach their mental well-being.

NeuroTechR3 is a biomedical device and digital health start-up that focuses on developing affordable rehabilitation technologies to enhance upper extremity function for individuals affected by brain injuries, including stroke and cerebral palsy. The company's flagship innovation, R3THATM, leverages machine learning and cloud technology to enable personalized telerehabilitation through engaging exergames designed to foster neuroplasticity. This system includes features such as motion tracking, analytics, and real-time biofeedback, which help clinicians provide high-quality, efficient care while improving patient recovery outcomes. Founded in 2020 by a team of four women, NeuroTechR3 emerged from the New Jersey Institute of Technology and Rutgers University, and operates from locations in Newark, NJ, and Philadelphia, PA. The company's expertise lies in biomedical engineering and computer science, positioning it to address the needs of the rehabilitation industry effectively. By advancing rehabilitation devices and machine learning-driven technologies, NeuroTechR3 aims to transform healthcare and make rehabilitation more accessible and sustainable for individuals with various impairments.

EnVision Endoscopy specializes in developing medical devices for endoscopic surgeries, focusing on enhancing clinical outcomes for patients and efficiency for healthcare providers. The company's flagship product is an image-guided suturing system that attaches to standard flexible endoscopes, facilitating tissue approximation during surgical procedures. This biodegradable, single-use device simplifies various surgical tasks, making it more accessible for gastroenterologists and surgeons. By streamlining procedures, EnVision Endoscopy aims to reduce both procedure times and associated mortality rates, thereby improving overall patient care in the medical field.

Access Airways specializes in developing innovative intubation-delivering devices designed to improve patient safety and clinician confidence during intubation procedures. Their minimally invasive articulating intubation stylet enhances access to challenging airways, allowing for safer, quicker, and less traumatic intubation experiences. The device features intuitive capabilities that streamline the intubation process, reducing the time required and minimizing the risk of failed attempts. It is compatible with both direct and video laryngoscopes, offering caregivers effortless control over the articulation of the tip to navigate complex anatomical structures effectively. By addressing the challenges associated with difficult intubation, Access Airways aims to elevate the standard of care in medical settings.

PolyLux is an advanced materials company based in Akron, Ohio, founded in 2016. The company specializes in developing innovative adhesive platforms that are activated by light. One of its notable products is a non-stick bandage that utilizes a photo-responsive adhesive, which adheres securely yet can be easily removed upon request. This design allows medical professionals to efficiently manage wound care by enabling the hassle-free removal and reapplication of dressings, ultimately facilitating faster healing.

Precision Theranostics is a biotechnology company based in Baltimore, Maryland, founded in 2019. The company focuses on developing prognosis-based intervention strategies aimed at the early detection and treatment of fatal diseases. Its innovative platform is designed to estimate disease progression, particularly for respiratory diseases and age-related disorders. By creating novel diagnostics, therapeutics, and prognosis-based therapies, Precision Theranostics enables healthcare providers to deliver timely diagnoses and interventions, ultimately improving survival rates and preventing the progression of chronic and fatal conditions.

CellDrop Biosciences, established in 2017 and based in Laramie, Wyoming, specializes in hydrogel-based technology for point-of-care diagnostics and targeted biomaterial delivery. The company focuses on developing hydrogel platforms that enable precise control over chemical and biological systems. Its innovations aim to facilitate the healing of equine musculoskeletal injuries efficiently, while also minimizing the risk of re-injury. By providing effective diagnostic and treatment solutions, CellDrop Biosciences addresses critical needs within the veterinary medical community.

Carrisan Technologies is a food technology company established in 2019 and located in Davis, California. The company specializes in developing innovative antimicrobial solutions aimed at preventing the spread of foodborne illnesses and minimizing food losses. Its technology encompasses antimicrobial coatings for equipment surfaces, methods for biofilm removal, and sanitation processes for food production. Carrisan Technologies serves various sectors, including agriculture, food processing, and foodservice, providing effective measures to combat cross-contamination in these industries.

NeuroTechR3 is a biomedical device and digital health start-up that focuses on developing affordable rehabilitation technologies to enhance upper extremity function for individuals affected by brain injuries, including stroke and cerebral palsy. The company's flagship innovation, R3THATM, leverages machine learning and cloud technology to enable personalized telerehabilitation through engaging exergames designed to foster neuroplasticity. This system includes features such as motion tracking, analytics, and real-time biofeedback, which help clinicians provide high-quality, efficient care while improving patient recovery outcomes. Founded in 2020 by a team of four women, NeuroTechR3 emerged from the New Jersey Institute of Technology and Rutgers University, and operates from locations in Newark, NJ, and Philadelphia, PA. The company's expertise lies in biomedical engineering and computer science, positioning it to address the needs of the rehabilitation industry effectively. By advancing rehabilitation devices and machine learning-driven technologies, NeuroTechR3 aims to transform healthcare and make rehabilitation more accessible and sustainable for individuals with various impairments.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Oncospace, Inc. is a medical technology company founded in 2018 and based in Baltimore, Maryland, specializing in personalized medicine for radiation oncology. It has developed an AI-powered platform that leverages clinical treatment data to create optimized treatment plans tailored to individual patients. This platform aims to enhance patient outcomes by minimizing side effects and improving the overall quality of life. Through the use of machine learning, Oncospace's technology establishes best-practice dosimetric goals, facilitating better planning and evaluation in radiation therapy. The company focuses on fostering collaborative relationships within the medical community, thereby advancing the field of radiation oncology.

Proov is a company that specializes in developing rapid response urine test strips for measuring progesterone, a hormone essential for confirming ovulation and supporting conception. Unlike traditional in-home tests that primarily measure hormones like LH, FSH, and estrogen during the early menstrual cycle, Proov's tests provide a more comprehensive assessment by specifically tracking progesterone levels. This capability allows women to not only predict ovulation but also to identify potential hormonal imbalances that may contribute to infertility or miscarriage. By enabling women to monitor their hormonal health at home, Proov offers a cost-effective alternative to fertility clinics and IVF treatments, empowering them to take control of their reproductive health.

HabitAware, Inc. is a company that develops and sells wearable devices aimed at helping individuals manage subconscious behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. Its flagship product, Liv, is a smart awareness bracelet equipped with motion sensors that alerts users when they engage in these habits. The accompanying Liv application provides training to help users recognize their problematic behaviors, track their progress, identify triggers, and offers strategies for replacing these habits with healthier alternatives. Founded in 2014 and headquartered in Minneapolis, Minnesota, HabitAware focuses on supporting both children and adults in gaining control over their compulsive behaviors. The company sells its products online, making its resources accessible to a wide audience.

Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation, and immunological disorders. Plexision's first patented product, the PleximmuneTM assay, predicts the risk of transplant rejection. The test is based on patent-pending technology to measure antigen-specific white blood cells. Testing services for transplant recipients and drug developers are provided at Plexision’s CLIA-certified, central laboratory in Pittsburgh. Plexision currently offers cell-based testing for personalized assessment of rejection risk after solid organ transplantation The Pleximmune blood test is the first such test offered for children with liver or intestine transplantation.

Travera, LLC is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in a unique measurement technology that utilizes the Suspended Microchannel Resonator (SMR), a MEMS device capable of detecting minute changes in the weight of individual cancer cells. This technology focuses on the Mass Accumulation Rate (MAR) biomarker, which indicates how cancer cells respond to various drugs within hours of exposure. By measuring these rapid changes, Travera enables oncologists to make informed decisions about which therapies to prescribe based on the actual responses of a patient’s tumor cells. This approach aims to enhance the effectiveness of cancer treatment by distinguishing between natural cell death and drug-induced cell death, thereby improving patient outcomes.

CoreMap, Inc. is dedicated to enhancing patient outcomes through advanced diagnostic technology tailored for electrophysiologists treating atrial fibrillation. Founded in 2016 and based in Winooski, Vermont, the company has developed a micro-electrode solution that allows for sequential mapping of tissue properties. This innovative technology addresses critical challenges in atrial fibrillation treatment, specifically poor spatial resolution and inadequate sample density. CoreMap's ultra-high resolution electrodes provide detailed insights into cardiac activation, even in the presence of fibrillation, thereby enabling medical practitioners to offer more effective treatment options for patients.

EnVision Endoscopy specializes in developing medical devices for endoscopic surgeries, focusing on enhancing clinical outcomes for patients and efficiency for healthcare providers. The company's flagship product is an image-guided suturing system that attaches to standard flexible endoscopes, facilitating tissue approximation during surgical procedures. This biodegradable, single-use device simplifies various surgical tasks, making it more accessible for gastroenterologists and surgeons. By streamlining procedures, EnVision Endoscopy aims to reduce both procedure times and associated mortality rates, thereby improving overall patient care in the medical field.

Manus Robotics is focused on developing a smart health and wellness device aimed at promoting independent and healthy living. The company offers a wearable robot that assists individuals with disabilities in their daily activities, providing intelligent support to enhance their quality of life. In addition to daily living assistance, the device collects and analyzes muscle data from patients, facilitating rehabilitation efforts and helping users regain independence.

Biocogniv Inc. specializes in developing artificial intelligence-powered diagnostic tools designed for hospitals, with a focus on enhancing clinical operations. Founded in 2019 and based in Burlington, Vermont, the company provides plugins for electronic health record (EHR) systems that enable real-time screening of patients for conditions such as COVID-19 by analyzing standard blood test results. Biocogniv's platform is particularly beneficial for emergency departments, as it can predict sepsis-related mortality and the need for intensive care unit admission. By leveraging the vast amounts of clinical and administrative data generated by hospitals, Biocogniv aims to improve the quality, cost, and accessibility of healthcare while facilitating accurate and non-invasive diagnostic methods.

3i DIAGNOSTICS provides technology that enables physicians to identify infectious microbes in less than minutes while leaving them intact for further testing. They help to make more informed infection-treatment decisions while practising antibiotic stewardship.

Unlocked Labs specializes in developing innovative probiotics aimed at addressing chronic health conditions by utilizing genetically optimized microbial strains. The company focuses on activating dormant microbial abilities to effectively digest compounds that can lead to health issues. Their first product targets the risk of kidney stones by breaking down stone-forming compounds derived from healthy foods like leafy vegetables. Unlocked Labs employs alternative regulatory pathways to expedite the availability of safe and effective probiotic solutions for consumers. By harnessing the natural detoxifying capabilities of symbiotic microbes, their products aim to reduce acid levels in the body, making them both affordable and accessible to a wide audience.

Hubly Surgical Inc. is a medical technology company focused on enhancing patient outcomes and improving the quality of care in neurosurgery. Founded in 2018 and based in San Francisco, California, with an additional office in Chicago, the company has developed an integrated electric drill system that replaces traditional free-hand techniques. This innovative device aims to reduce the rate of lethal complications associated with surgical drilling and is designed to facilitate bedside intracranial access, decreasing the reliance on operating rooms. Hubly's mission is to make its safety technology the standard of care for medical drilling, ensuring that both standard and underserved settings can benefit from improved surgical procedures.

AxonDx is a company focused on the detection of circulating tumor cells (CTCs) in blood samples, which serve as a crucial indicator of both primary tumors and potential metastases. Their innovative nCYTE™ technology allows for the rapid scanning of un-enriched blood samples, identifying all classes of CTCs shed by solid tumors within minutes. This method not only enhances the accuracy of detection but also provides detailed morphological and molecular characterization of the identified cells. By enabling faster and more comprehensive insights into a patient’s cancer status, AxonDx's solutions support personalized medical treatment and early cancer detection. The company operates on a “razor and blade” business model, selling nCYTE™ instruments and associated diagnostic kits, making their technology accessible at the point of care. This advancement represents a significant improvement over existing CTC detection methods, which are often slow, costly, and less sensitive.

Iterex is dedicated to revolutionizing at-home care of chronic illnesses through early, cost effective, personalized mobile digital health applications.

Averto Medical is a manufacturer of medical devices focused on addressing gastrointestinal diseases. The company specializes in developing innovative solutions designed to facilitate minimally invasive colorectal tumor removal, which aims to reduce the need for multiple surgical procedures and associated complications. By providing effective medical care options for patients suffering from gastrointestinal disorders, Averto Medical seeks to improve patient outcomes and streamline treatment processes in this critical area of healthcare.

HabitAware, Inc. is a company that develops and sells wearable devices aimed at helping individuals manage subconscious behaviors such as hair pulling, nail biting, skin picking, and thumb sucking. Its flagship product, Liv, is a smart awareness bracelet equipped with motion sensors that alerts users when they engage in these habits. The accompanying Liv application provides training to help users recognize their problematic behaviors, track their progress, identify triggers, and offers strategies for replacing these habits with healthier alternatives. Founded in 2014 and headquartered in Minneapolis, Minnesota, HabitAware focuses on supporting both children and adults in gaining control over their compulsive behaviors. The company sells its products online, making its resources accessible to a wide audience.

AnkyrBio, headquartered in Pittsburgh, Pennsylvania, is a biotechnology company specializing in the development of a proprietary drug delivery system. This system enhances the efficacy of therapies in wet epithelial areas by enabling therapeutics to be administered as eye drops, remaining active on the eye's surface, and providing localized treatment, extended drug duration, and reduced systemic toxicity.

HX Innovations, Inc. is a Delaware-based company specializing in human performance and biomechanics testing. The company has developed patent-pending GenL Movement Technology, which offers data-driven neuroergonomic and biomechanic solutions. This technology is designed to measure muscle activity and physical performance while assessing knee injury risk. By providing movement analytics, HX Innovations enables trainers and coaches to evaluate player performance, establish effective strength and conditioning strategies, and create return-to-play protocols. These capabilities assist clients in developing health and performance programs and products that optimize human performance.

TAO Connect, Inc. offers an online treatment program designed to address various mental health issues, including generalized anxiety, social anxiety, performance anxiety, panic, and more. The company's cognitive behavioral treatment module enables patients to actively engage in behavioral change while allowing clinicians to monitor progress and symptom changes over time. This module features online educational resources, video conferencing, text messaging, push notifications, and daily practice assignments accessible via smartphones. Additionally, TAO Connect provides treatments for substance abuse recovery, mindfulness, depression, and trauma, as well as training for its treatment modules. The services are utilized by a diverse range of organizations, including college counseling centers, wellness centers, employee assistance programs, outpatient clinics, VA medical centers, and private practitioners. Founded in 2014 and based in Saint Petersburg, Florida, TAO Connect is dedicated to making mental health treatment more affordable and accessible, particularly for individuals who have historically faced barriers to care.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Oxalo Therapeutics is focused on developing innovative drug therapies aimed at treating rare kidney diseases and preventing recurring kidney stones. The company specifically targets primary hyperoxaluria and other oxalate-related pathologies through a novel approach that utilizes a gut bacterium to facilitate the safe removal of oxalate from the body. By mimicking natural mechanisms, Oxalo Therapeutics seeks to provide effective treatment options for patients suffering from conditions associated with high levels of oxalate, thereby improving their quality of life and reducing the incidence of kidney stone recurrence. The company's expertise in the microbiome and translational research underpins its commitment to advancing early-stage technology in the field of kidney health.

Oncospace, Inc. is a medical technology company founded in 2018 and based in Baltimore, Maryland, specializing in personalized medicine for radiation oncology. It has developed an AI-powered platform that leverages clinical treatment data to create optimized treatment plans tailored to individual patients. This platform aims to enhance patient outcomes by minimizing side effects and improving the overall quality of life. Through the use of machine learning, Oncospace's technology establishes best-practice dosimetric goals, facilitating better planning and evaluation in radiation therapy. The company focuses on fostering collaborative relationships within the medical community, thereby advancing the field of radiation oncology.

EnVision Endoscopy specializes in developing medical devices for endoscopic surgeries, focusing on enhancing clinical outcomes for patients and efficiency for healthcare providers. The company's flagship product is an image-guided suturing system that attaches to standard flexible endoscopes, facilitating tissue approximation during surgical procedures. This biodegradable, single-use device simplifies various surgical tasks, making it more accessible for gastroenterologists and surgeons. By streamlining procedures, EnVision Endoscopy aims to reduce both procedure times and associated mortality rates, thereby improving overall patient care in the medical field.

Teaching It Right is an educational curriculum development company focused on serving children diagnosed with autism spectrum disorder. The company creates supplementary materials and curricula tailored for individuals and educational institutions, as well as professionals involved in autism education. Their offerings include an integrated mobile application designed to teach social skills and a multi-sensory therapy program aimed at enhancing eye contact. These services are intended to help children engage more fully in society, prepare for self-sufficiency, and improve their future employment opportunities.

Azitra Inc. is a clinical-stage medical dermatology company based in Farmington, Connecticut, focused on developing microbiome-based therapeutics for skin diseases. Established in 2014, Azitra leverages its proprietary platform, which includes a microbial library of bacterial strains, to discover and create novel treatments for adverse skin conditions. The company's technology, developed in collaboration with researchers at Yale University and the Jackson Laboratory, is centered around a specific strain of the natural commensal bacteria Staphylococcus epidermidis. Additionally, Azitra employs artificial intelligence and machine learning to enhance the screening and prediction of therapeutic characteristics within its microbial library. By utilizing engineered proteins and live biotherapeutic products for topical application, Azitra aims to advance precision dermatology.

PediaMetrix Inc. is a company focused on developing innovative digital solutions for pediatric head measurement and monitoring. Founded in 2018 by alumni from Johns Hopkins, NIH, and Oxford, the company is based in Rockville, Maryland. Its primary product, SoftSpot, is a mobile application that leverages artificial intelligence and computer vision to provide accurate measurements of infants' head shapes. This app allows parents to receive personalized repositioning instructions and enables pediatricians to access easy-to-understand data analysis, facilitating timely and effective care. By focusing on early detection and management of head shape abnormalities, PediaMetrix aims to enhance healthcare outcomes and reduce costs associated with pediatric care.

Levisonics is a manufacturer of advanced blood coagulation instruments that specialize in non-contact analysis for blood coagulation and fluid quality control testing. Their products facilitate the assessment of bleeding and thrombosis risks through innovative fluid rheological measurement techniques. In addition to medical applications, Levisonics' technology can be employed in real-time monitoring of the quality of food, liquid, and gel products during production or processing, ensuring safety and compliance in various industries.

Travera, LLC is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in a unique measurement technology that utilizes the Suspended Microchannel Resonator (SMR), a MEMS device capable of detecting minute changes in the weight of individual cancer cells. This technology focuses on the Mass Accumulation Rate (MAR) biomarker, which indicates how cancer cells respond to various drugs within hours of exposure. By measuring these rapid changes, Travera enables oncologists to make informed decisions about which therapies to prescribe based on the actual responses of a patient’s tumor cells. This approach aims to enhance the effectiveness of cancer treatment by distinguishing between natural cell death and drug-induced cell death, thereby improving patient outcomes.

CorInnova Incorporated, founded in 2004 and based in Houston, Texas, specializes in device-based therapies aimed at treating congestive heart failure. The company is known for its innovative non-blood-contacting soft robotic cardiac assist device, which has the potential to significantly increase the number of heart failure patients eligible for life-saving device therapies. By focusing on advanced technological solutions, CorInnova seeks to improve outcomes for individuals suffering from this serious condition.

Rumi Scientific is a research-oriented company focused on developing innovative medications and treatments for genetic disorders affecting the central nervous system, particularly Huntington's Disease. The company utilizes a proprietary human organoid platform that simulates human development in vitro, integrating gene editing techniques with multi-cellular self-organization to create defined diseased embryonic tissues. This advanced platform facilitates drug discovery and high-throughput screening, leveraging artificial intelligence to identify potential treatments. By emphasizing synthetic human embryology in both healthy and diseased contexts, Rumi Scientific aims to advance therapeutic options for numerous genetic conditions that currently lack effective cures. The company's approach combines single-cell, time-lapse imaging with customized analytic tools, resulting in a more efficient and cost-effective drug development process that enhances treatment success rates and outcomes for patients.

Cybele Microbiome is a company focused on enhancing skin health through precision control of the microbiome. Utilizing a proprietary AI platform that integrates machine learning with advanced biotechnology, Cybele Microbiome develops customized skincare products aimed at improving the skin's natural barrier. The company's approach includes genetic sequencing methods and the use of sustainable nutrient sources to create targeted natural solutions that support the microbiome. By leveraging AI tools and microbiome science, Cybele Microbiome seeks to revolutionize skincare, enabling customers to maintain skin integrity while promoting overall health and longevity.

The University of Vermont Health Network is a network of five partner hospitals serving the residents of Vermont and northern New York. With over 4,000 health care providers, they collaborate to provide high-quality care efficiently and close to home. Each hospital within the network is dedicated to its local community, offering compassionate and personalized care driven by the latest medical advancements and delivered by skilled professionals. This network aims to enhance the overall health and well-being of the communities they serve through their collective expertise and commitment to excellence in healthcare.

Iterex is dedicated to revolutionizing at-home care of chronic illnesses through early, cost effective, personalized mobile digital health applications.

PolyLux is an advanced materials company based in Akron, Ohio, founded in 2016. The company specializes in developing innovative adhesive platforms that are activated by light. One of its notable products is a non-stick bandage that utilizes a photo-responsive adhesive, which adheres securely yet can be easily removed upon request. This design allows medical professionals to efficiently manage wound care by enabling the hassle-free removal and reapplication of dressings, ultimately facilitating faster healing.

3i DIAGNOSTICS provides technology that enables physicians to identify infectious microbes in less than minutes while leaving them intact for further testing. They help to make more informed infection-treatment decisions while practising antibiotic stewardship.

Norwich University is a nonprofit educational institution located in Northfield, Vermont, founded in 1819. It offers a diverse range of academic programs, including undergraduate degrees in liberal arts, sciences, and professional fields such as Architecture, Computer Science, Engineering, Pre-Law, and Pre-Medicine. The university is notable for its ROTC program, which trains cadets while also accommodating non-cadets who seek high-quality education. Graduate degrees are predominantly delivered online, with options available in Diplomacy, Education, Military History, Civil Engineering, Public Administration, and Nursing. Norwich employs an experiential learning model that integrates practical and theoretical approaches to education, enhancing knowledge retention. The university provides various financial aid opportunities, including loans, grants, and scholarships, particularly benefitting current and former military personnel. Admission requirements include submission of an application, a personal statement, transcripts, test scores, and letters of recommendation, which are strongly encouraged.

MediCool Technologies specializes in developing innovative therapies aimed at the painless prevention and termination of dangerous cardiac arrhythmias, including atrial fibrillation and other related disorders. The company focuses on providing effective treatment options that allow patients to manage irregular heartbeats without experiencing pain. By leveraging advanced technology, MediCool strives to enhance patient outcomes and improve the overall experience for those affected by these serious cardiac conditions.

MyHomecareBiz specializes in developing intuitive software solutions for the home health care industry, focusing on automating essential processes such as patient care, billing, scheduling, and physician orders. Established in 1998, the company’s software is crafted with the input of home health care professionals, ensuring that it meets the practical needs of nurses and therapists. Key products include SmartDX, a mobile application that tracks Value-Based Purchasing outcomes and facilitates real-time updates to care plans, and TurboClaim, an efficient billing system that streamlines the claims process by automatically scrubbing and submitting claims while managing payment postings. This allows health care providers to concentrate on delivering quality patient care rather than dealing with administrative tasks.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

DFusion is a science-based behavioral health research and development company that focuses on promoting behavior change for health, prevention, and adherence. Leveraging evidence-based models and learning theories, DFusion creates innovative applications of both modern and traditional technologies aimed at enhancing health outcomes. The company develops smartphone, tablet, and web applications that are informed by behavioral research, ensuring an optimal user experience. Additionally, DFusion offers consultation services and professional development opportunities within the health and education sectors. Their team, comprised of scientists and innovators, is dedicated to challenging existing paradigms and improving the health and well-being of individuals throughout their lifespans. DFusion operates from offices in Scotts Valley and Oakland, California.

CrossLife Technologies is a life science company focused on developing and commercializing molecular diagnostics for both infectious and non-communicable diseases. The firm specializes in creating diagnostic tools based on genetic material, particularly nucleic acids and DNA. Their technologies enable the direct detection of infectious pathogens from various sample types, eliminating the need for complex sample preparation or specialized instrumentation. CrossLife Technologies aims to reduce suffering and improve health outcomes by providing accurate diagnostic solutions for diseases such as HIV, malaria, chikungunya, and influenza.

Teaching It Right is an educational curriculum development company focused on serving children diagnosed with autism spectrum disorder. The company creates supplementary materials and curricula tailored for individuals and educational institutions, as well as professionals involved in autism education. Their offerings include an integrated mobile application designed to teach social skills and a multi-sensory therapy program aimed at enhancing eye contact. These services are intended to help children engage more fully in society, prepare for self-sufficiency, and improve their future employment opportunities.

Shasqi, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2018. It specializes in the development of a unique platform known as CAPAC (Click Activated Protodrugs Against Cancer), which utilizes click chemistry for localized drug activation. This innovative approach allows for the activation of chemotherapeutic agents directly at tumor sites, thereby concentrating the drug's effects where they are most needed while minimizing systemic toxicity. The technology involves injecting a polymer gel that contains a click chemistry reagent in the tumor area, which subsequently activates a systemically administered protodrug when they interact. Shasqi's platform has demonstrated efficacy in human trials, indicating its potential to enhance cancer treatment outcomes and paving the way for future advancements in click-chemistry-based therapies.

MediCool Technologies specializes in developing innovative therapies aimed at the painless prevention and termination of dangerous cardiac arrhythmias, including atrial fibrillation and other related disorders. The company focuses on providing effective treatment options that allow patients to manage irregular heartbeats without experiencing pain. By leveraging advanced technology, MediCool strives to enhance patient outcomes and improve the overall experience for those affected by these serious cardiac conditions.

Workit Health, Inc. is a provider of online therapeutic content and professional counseling services focused on substance use recovery. Established in 2014 and based in Ann Arbor, Michigan, the company operates the Workit platform, which offers clinically proven telemedicine treatment for substance use disorder, including online therapy, medication-assisted treatment, psychiatric support, and primary care. Workit Health's services are designed to help individuals achieve long-term recovery from drugs and alcohol while minimizing disruption to their daily lives. The platform facilitates access to on-demand, in-person, and virtual medical and psychosocial support, catering to a wide range of clients including employers, educational institutions, healthcare facilities, and recovery communities. Additionally, Workit Health provides accredited opioid addiction treatment featuring buprenorphine, enhancing its commitment to harm reduction in addiction care. The company has locations in California, New Jersey, Alaska, and Washington.

TAO Connect, Inc. offers an online treatment program designed to address various mental health issues, including generalized anxiety, social anxiety, performance anxiety, panic, and more. The company's cognitive behavioral treatment module enables patients to actively engage in behavioral change while allowing clinicians to monitor progress and symptom changes over time. This module features online educational resources, video conferencing, text messaging, push notifications, and daily practice assignments accessible via smartphones. Additionally, TAO Connect provides treatments for substance abuse recovery, mindfulness, depression, and trauma, as well as training for its treatment modules. The services are utilized by a diverse range of organizations, including college counseling centers, wellness centers, employee assistance programs, outpatient clinics, VA medical centers, and private practitioners. Founded in 2014 and based in Saint Petersburg, Florida, TAO Connect is dedicated to making mental health treatment more affordable and accessible, particularly for individuals who have historically faced barriers to care.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

iotaMotion, Inc. is a company based in Iowa City, Iowa, that specializes in the development and manufacture of cochlear ear implants aimed at treating hearing loss. Founded in 2015, the company has created a robotic-assisted surgical system designed to standardize the insertion of cochlear implant electrodes. This innovative technology enhances surgical precision by controlling the speed and acceleration of electrode insertion, which helps to reduce variability in surgical procedures. By personalizing the approach to each patient, iotaMotion enables surgeons to provide more accurate and tailored cochlear interventions, ultimately expanding access to these critical treatments for both patients and healthcare providers.

Triton Algae Innovations, Ltd. specializes in the development of proteins derived from natural algae, particularly the microalgae Chlamydomonas reinhardtii. Incorporated in 2012 and based in San Diego, California, the company has established a platform that allows for the scalable and environmentally friendly production of a variety of natural proteins, including enzymes, antibodies, hormones, and antioxidants. Triton's innovations address food and feed shortages by offering vegan plant proteins that boast complete amino acid profiles and are rich in essential nutrients such as omega-3 fatty acids and vitamin A. Their products cater to diverse market sectors, including infant formulas, nutraceuticals, therapeutics, and cosmetics, while also promoting benefits for gut health. Through its pioneering biotechnology tools and GRAS-certified processes, Triton aims to enhance nutritional health and provide better-tasting food alternatives.

AbiliLife, Inc. is a Pennsylvania-based company focused on creating biomedical solutions for individuals suffering from neurodegenerative disorders, particularly Parkinson's disease. Incorporated in 2014, AbiliLife designs and manufactures innovative products aimed at enhancing the quality of life for patients. One of its key offerings is Calibrace, a specialized brace that assists patients in restoring equilibrium through a back tensioning system. This product is designed to improve posture, positioning, and balance, providing users with postural stability and relief from discomfort associated with neurodegenerative conditions.

PhotoniCare, Inc. is a medical device company based in Champaign, Illinois, founded in 2013. The company specializes in developing innovative diagnostic tools for middle ear infections, notably the TOMi Scope. This handheld device employs advanced light-based technology, specifically near-infrared light waves, to create 3D images of the middle ear by seeing through the eardrum. This capability allows physicians to visualize the middle ear directly and safely, enabling them to assess its condition quickly and accurately. By determining the contents of the middle ear, clinicians can make informed decisions regarding the need for antibiotics or surgical interventions. PhotoniCare's technology not only addresses otology but also presents potential for growth in other medical fields.

Shasqi, Inc. is a biopharmaceutical company based in San Francisco, California, founded in 2018. It specializes in the development of a unique platform known as CAPAC (Click Activated Protodrugs Against Cancer), which utilizes click chemistry for localized drug activation. This innovative approach allows for the activation of chemotherapeutic agents directly at tumor sites, thereby concentrating the drug's effects where they are most needed while minimizing systemic toxicity. The technology involves injecting a polymer gel that contains a click chemistry reagent in the tumor area, which subsequently activates a systemically administered protodrug when they interact. Shasqi's platform has demonstrated efficacy in human trials, indicating its potential to enhance cancer treatment outcomes and paving the way for future advancements in click-chemistry-based therapies.

Digidence develops software tools for oncology departments and practices of patient outcomes. They offer a range of services, including data collecting and analysis, interventional studies, pragmatic studies, patient-centered research, outcomes research, patient-reported outcomes, pharmaceuticals, life sciences, and software development.

Cardiio is a digital health company that emerged from MIT, specializing in the development of intelligent algorithms that utilize smartphones and wearables for health monitoring. The company focuses on creating software applications that transform smartphone cameras into biosensors, enabling users to measure their heart rates accurately. Their flagship product, the Cardiio Heart Rate Monitor, is a mobile app that allows individuals to track their heart rate for general wellness and fitness purposes. By leveraging machine learning, Cardiio aims to enhance the monitoring of wellness, fitness, and chronic diseases, making health management more accessible and efficient for users.

OESH Shoes provides groundbreaking research on the effects of common features of women’s shoes on the body—beyond the foot. Their OESHers wear multiple styles and colours of OESH as their brand of choice to maintain optimal fitness, comfort, and health with specific conditions.

TAO Connect, Inc. offers an online treatment program designed to address various mental health issues, including generalized anxiety, social anxiety, performance anxiety, panic, and more. The company's cognitive behavioral treatment module enables patients to actively engage in behavioral change while allowing clinicians to monitor progress and symptom changes over time. This module features online educational resources, video conferencing, text messaging, push notifications, and daily practice assignments accessible via smartphones. Additionally, TAO Connect provides treatments for substance abuse recovery, mindfulness, depression, and trauma, as well as training for its treatment modules. The services are utilized by a diverse range of organizations, including college counseling centers, wellness centers, employee assistance programs, outpatient clinics, VA medical centers, and private practitioners. Founded in 2014 and based in Saint Petersburg, Florida, TAO Connect is dedicated to making mental health treatment more affordable and accessible, particularly for individuals who have historically faced barriers to care.

Triton Algae Innovations, Ltd. specializes in the development of proteins derived from natural algae, particularly the microalgae Chlamydomonas reinhardtii. Incorporated in 2012 and based in San Diego, California, the company has established a platform that allows for the scalable and environmentally friendly production of a variety of natural proteins, including enzymes, antibodies, hormones, and antioxidants. Triton's innovations address food and feed shortages by offering vegan plant proteins that boast complete amino acid profiles and are rich in essential nutrients such as omega-3 fatty acids and vitamin A. Their products cater to diverse market sectors, including infant formulas, nutraceuticals, therapeutics, and cosmetics, while also promoting benefits for gut health. Through its pioneering biotechnology tools and GRAS-certified processes, Triton aims to enhance nutritional health and provide better-tasting food alternatives.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

Digidence develops software tools for oncology departments and practices of patient outcomes. They offer a range of services, including data collecting and analysis, interventional studies, pragmatic studies, patient-centered research, outcomes research, patient-reported outcomes, pharmaceuticals, life sciences, and software development.

Gliimpse is a health record management platform that aims to empower individuals to manage and share their personal health data securely. By addressing the challenges of fragmented medical records, Gliimpse aggregates data from various sources into a cohesive, patient-owned health profile. This platform allows users to track their medical history, access information from multiple patient portals, and include their own health data, facilitating a comprehensive overview of their health. Ultimately, Gliimpse provides a means for patients to take control of their health records and share them with trusted parties, enhancing the management of personal health information.

Solinas Medical is a medical device company focused on enhancing vascular access technology for hemodialysis. The company aims to improve patient outcomes by addressing complications associated with cannulation, which can lead to leakage and other issues during treatment. By developing a specialized patch designed for these challenges, Solinas Medical enables healthcare professionals to perform procedures more effectively, ultimately improving the quality of life for hemodialysis patients. In addition to enhancing patient care, their innovations also contribute to reducing overall healthcare costs associated with complications in vascular access procedures.

MedShape is a privately held medical device company founded in 2005 based on a portfolio of proprietary surgical solutions that use its patented adaptive shape memory healing technologies to address the increasing demand for improved joint fusion, sports medicine, and musculoskeletal trauma products. MedShape® has enjoyed long-term support from Hills Capital Management, the Georgia Research Alliance (GRA), the National Science Foundation (NSF), the National Institutes of Health (NIH), and In-Q-Tel.

Sheepdog Sciences offers learning services for individuals diagnosed with attention deficit hyperactivity. Sheepdog Sciences was founded in 2011 by Daniel Wetmore and Alexander Butterwick and is based in California.

CREmedical, founded in 2011 and headquartered in Kingston, Rhode Island, specializes in the development of electroencephalography equipment aimed at enhancing the understanding of brain function and aiding in the diagnosis and treatment of mental illnesses and brain disorders. The company's innovative devices monitor brainwaves and are designed to facilitate the recording of electroencephalograms (EEGs) in home settings. This technology not only assists healthcare professionals in detecting life-threatening events but also has the potential to prevent seizures, thereby improving patient care and outcomes.

Innovative Healthcare Solutions provides billing and account management services with consulting and medical billing & coding services.

CardioWise, Inc. is a cardiac imaging analysis company that specializes in developing advanced heart analysis software. Founded in 2010 and based in Fayetteville, Arkansas, CardioWise's primary product is its non-invasive cardiac CT analysis software, which includes the Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ). This software utilizes high-resolution cardiac CT scans to create a quantified 4D model of the human heart, enabling cardiologists to conduct comprehensive and objective evaluations of heart function. The platform employs artificial intelligence algorithms to enhance diagnostic accuracy, facilitate timely interventions, and ultimately improve the standard of cardiac care while reducing healthcare costs. By providing easy-to-interpret 3D color maps of heart function through a cloud-based, secure portal, CardioWise aims to make cardiac diagnostics more accessible for both healthcare providers and patients.

EnGen Bio, LLC is a development-stage biotechnology company based in Redwood City, California, focused on the discovery and development of vaccines and therapeutic antibodies targeting influenza. The company aims to create a universal vaccine for Type A influenza, leveraging its unique approach to targeting the M1 matrix protein of the virus. EnGen Bio's innovative strategy seeks to provide long-lasting immunity through neutralizing antibody responses in both humans and animals. Established in 2016, the company is actively pursuing opportunities to advance its vaccine and therapeutic candidates, benefiting from significant government funding that supports the development of influenza-related treatments through clinical trials and potential market introduction.

GigaGen, Inc. is a biopharmaceutical company focused on developing innovative antibody therapies for cancer and immune deficiencies. Founded in 2010 and based in South San Francisco, California, GigaGen employs advanced technologies such as microfluidics, bioinformatics, sequencing, and genetic engineering to analyze B and T cell repertoires. This enables the identification of full-length, natively paired antibodies and T cell receptors. The company is advancing a pipeline that includes novel oncology antibody drug combinations and the first recombinant polyclonal hyperimmune gammaglobulin. GigaGen's proprietary discovery technology allows for the rapid characterization of cells within complex immune systems, which facilitates the selection of drug targets and the identification of potential drug candidates, ultimately enhancing preclinical efficacy assessments.

GenEndeavor is a biotechnology firm that creates platforms for the next generation of molecular technology to enable quick and accurate identification of infectious and genetic illnesses in real time at the point of presentation. Its objective is to increase access to extremely early genetic and infectious illness screening. They aim to identify diseases while they are still curable by lowering the detection limit of uncommon mutations and infections. Its assay technology platforms will make point-of-care testing sensitive, quick, and economical.